Hospital Universitario La Fe -ko ikertzaileekin lankidetzan egindako argitalpenak (35)

2024

  1. Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis

    Frontiers in Neurology, Vol. 15

2023

  1. Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

    Frontiers in Pharmacology, Vol. 14

  2. Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease Prophylaxis

    Transplantation and Cellular Therapy, Vol. 29, Núm. 10, pp. 610.e1-610.e12

  3. Reliability, validity and distribution of the Spanish female sexual function index in women with relapsing multiple sclerosis

    BMC Women's Health, Vol. 23, Núm. 1

  4. Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience

    Frontiers in Neurology, Vol. 14

2022

  1. Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

    Journal of Neurology, Vol. 269, Núm. 7, pp. 3676-3681

  2. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis

    Frontiers in Immunology, Vol. 13

  3. NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity

    Journal of Neurology, Vol. 269, Núm. 7, pp. 3495-3500

  4. Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis

    Frontiers in Neurology, Vol. 13

  5. Patient's perspective in clinical practice to assess and predict disability in multiple sclerosis

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Epilepsy, status epilepticus, and hemiplegic migraine coexisting with a novel SLC4A4 mutation

    Neurological Sciences, Vol. 42, Núm. 9, pp. 3647-3654

  2. Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

    Frontiers in Neurology, Vol. 12

2020

  1. CSF chitinase 3-like-1 association with disability of primary progressive MS

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 7, Núm. 5

  2. Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-α treatment

    Journal of Hepatology, Vol. 73, Núm. 3, pp. 582-592

2019

  1. Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype

    Frontiers in Neurology, Vol. 10

  2. Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis

    Frontiers in Neurology, Vol. 10

  3. Desarrollo y optimización de un modelo animal para el estudio de las células ganglionares en enfermedad degenerativa de la retina y nervio óptico

    Archivos de la Sociedad Española de Oftalmologia, Vol. 94, Núm. 6, pp. 263-272

  4. Evaluation of the retina and optic nerve after the use of stem cells for neurodegenerative disorders in an animal model

    Revista Mexicana de Oftalmologia, Vol. 93, Núm. 6, pp. 264-273

  5. Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease

    Multiple Sclerosis and Related Disorders, Vol. 27, pp. 406-408

  6. Silent Progression or Bout Onset Progressive Multiple Sclerosis?

    Annals of Neurology